易方达沪深300医药卫生 ETF SIP Calculator
Calculate historical returns and project future compounding for 易方达医药 ETF. Test different monthly amounts, tenures, and step-up scenarios using real historical NAV performance.
Category
行业主题 / 医药医疗
AUM
¥380 亿元
Expense Ratio
0.50%
Fund Manager
余海燕
易方达医药 ETF Historical SIP Performance & Returns Table
Historical value of standard monthly SIP investments based on actual fund CAGRs.
| Monthly SIP | 3 Years @ -3.8% CAGR | 5 Years @ -10.2% CAGR | 10 Years @ 1.6% CAGR |
|---|---|---|---|
| ¥200/mo | ¥6,792 Invested: ¥7,200 | ¥9,360 Invested: ¥12,000 | ¥25,989 Invested: ¥24,000 |
| ¥500/mo | ¥16,981 Invested: ¥18,000 | ¥23,399 Invested: ¥30,000 | ¥64,972 Invested: ¥60,000 |
| ¥1,000/mo | ¥33,962 Invested: ¥36,000 | ¥46,798 Invested: ¥60,000 | ¥129,944 Invested: ¥120,000 |
| ¥2,000/mo | ¥67,923 Invested: ¥72,000 | ¥93,595 Invested: ¥120,000 | ¥259,888 Invested: ¥240,000 |
| ¥5,000/mo | ¥169,809 Invested: ¥180,000 | ¥233,988 Invested: ¥300,000 | ¥649,720 Invested: ¥600,000 |
* Projections calculated using actual historical 3-year (-3.81%), 5-year (-10.16%), and 10-year (1.56%) performance data. Actual mutual fund returns fluctuate with market NAV.
About 易方达沪深300医药卫生 ETF
跟踪中国医药卫生行业龙头上市公司，涵盖创新药研发、医疗器械制造、CXO医药外包及特色中药全产业链核心企业。
Investment Strategy
布局人口老龄化背景下长期刚需与医疗消费升级机遇，兼顾防御性刚需用药与创新药海外授权爆发潜力。
Key Facts
- 医药板块历史最久、知名度最高的场内指数工具之一
- 包含恒瑞医药、迈瑞医疗、药明康德等行业领军巨头
- 经历充分估值调整后处于历史级长期性价比配置区间
Historical Returns
3-Year CAGR
-3.81%
5-Year CAGR
-10.16%
10-Year CAGR
+1.56%
Benchmark
沪深300医药卫生指数 (CSI 300 Healthcare Index)
过往业绩不代表未来表现。历史年化回报基于交易所官方月度收盘净值计算。
Top Holdings & Sector Allocation
As of September 2026, 易方达医药 ETF's portfolio includes:
Top 5 Holdings
- 迈瑞医疗 (300760)
- 恒瑞医药 (600276)
- 药明康德 (603259)
- 爱尔眼科 (300015)
- 片仔癀 (600436)
Sector Allocation
化学制药与创新药 58%, 医疗器械 24%, 医疗服务 12%, 生物制品 6%
Who Is This Fund Suitable For?
认可医药健康行业长期刚需逻辑、愿通过定投摊薄行业周期波动的长期投资者。
Similar Funds to Consider
Or compare side by side using our main SIP calculator — you can test different funds with the same investment amount and dates to see which performed better.
Other Tools for 易方达医药 ETF Investors
- FIRE Calculator — Plan your retirement corpus with 易方达医药 ETF as part of your portfolio
- Cost of Delay Calculator — See how much delaying your SIP in 易方达医药 ETF could cost you
- SIP vs EMI Calculator — Compare investing in 易方达医药 ETF vs paying off loans
Frequently Asked Questions About 易方达医药 ETF
What is the historical SIP return of 易方达医药 ETF?
Based on the latest data, 易方达医药 ETF has delivered an annualized return (CAGR) of -3.81% over 3 years, -10.16% over 5 years, and +1.56% over 10 years. Past performance does not guarantee future results.
How is 易方达医药 ETF SIP return calculated?
SIP returns are calculated using the XIRR (Extended Internal Rate of Return) method. Each monthly installment buys units at the fund's Net Asset Value (NAV) on that specific day. When markets are down, your SIP buys more units, and when markets are up, it buys fewer units (rupee cost averaging). Our calculator replays this exact process using historical NAV data to compute the precise current value of your accumulated units.
How much return would ¥1,000 monthly SIP in 易方达医药 ETF generate over 5 years?
At an estimated annual return rate of -10.16%, a monthly ¥1,000 investment (¥60,000 total invested) would grow to approximately ¥46,798 in 5 years, yielding an estimated wealth gain of -¥13,202. Use our interactive calculator above to test custom amounts with actual historical NAV data.
What are the top holdings in 易方达医药 ETF?
易方达医药 ETF's top holdings include 迈瑞医疗 (300760), 恒瑞医药 (600276), 药明康德 (603259), and 爱尔眼科 (300015). The fund's sector allocation is 化学制药与创新药 58%, 医疗器械 24%, 医疗服务 12%, 生物制品 6%.
What is the risk profile of 易方达医药 ETF?
易方达医药 ETF is a 行业主题 / 医药医疗 fund with moderate to high risk depending on market conditions. Investors should assess their risk tolerance before investing..
What are the tax implications of investing in 易方达医药 ETF?
In mainland China, trading domestic ETFs via secondary exchange accounts is exempt from stamp duty and dividend withholding is subject to standard mutual fund tax policies.
Data last updated: September 2026 | Fund data sourced from SSE, SZSE and official public disclosures
Ready to check 易方达医药 ETF returns?
Use our free calculator with real historical NAV data — no sign-up needed.
Open 易方达医药 ETF SIP Calculator →